top of page

Albertsons posts Q4 results

  • 4 days ago
  • 1 min read

Albertsons Companies delivered steady fourth-quarter results, with digital growth and loyalty gains continuing to build momentum even as pharmacy pressures weighed on performance. A $774 million opioid settlement charge led to a reported net loss, though the company emphasized that the agreement resolves most claims without admitting wrongdoing. At the same time, Albertsons raised its dividend by 13%, signaling confidence in its cash flow and long-term outlook as it balances near-term headwinds with continued investment in digital, store upgrades, and operational efficiency.



MMR April 14, 2026  . 2:51 PM

4 min read

Comments


bottom of page